title: Aspirin for CV prevention -- for which patients?
abstract: Put your patient on aspirin? Take him off? Here's what you need to know to get it right.
authors: University of Rhode Island College of Pharmacy, Kingston, RI 02881, USA. anitaj@uri.edu
authors: Anita N
authors: AN
authors: Jackson
authors: Anne L
authors: AL
authors: Hume
mesh_terms: D000368:Aged; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy; D004351:Drug Resistance; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012737:Sex Factors; D014481:United States
chemical_list: D005343:Fibrinolytic Agents; D001241:Aspirin